Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Impact of Ketamine on Epigenetic Age (IKEA)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05294835

Organisation Name: TruDiagnostic

Overal Status: Recruiting

Start Date: April 1, 2022

Last Update: September 8, 2022

Lead Sponsor: TruDiagnostic

Brief Summary: This is a prospective, clinical pilot study (n=20) to evaluate the impact of a ketamine treatment for Major Depressive Disorder (MDD) or Post Traumatic Stress Disorder (PTSD) on epigenetic aging by the TruAge epigenetic age laboratory test.

Conditions:
  • Depression
  • Post Traumatic Stress Disorder


Total execution time in seconds: 0.30001783370972